share_log

Biora Therapeutics: Biora Therapeutics, Inc. - Reverse Split Option Symbol: BIOR New Symbol: BIOR1

Biora Therapeutics: Biora Therapeutics, Inc. - Reverse Split Option Symbol: BIOR New Symbol: BIOR1

Biora Therapeutics：Biora Therapeutics，Inc. - 反向拆分標的：BIOR 新標的：BIOR1
OCC期權清算公司 ·  2024/10/17 03:14

Moomoo AI 已提取核心訊息

Biora Therapeutics, Inc. (BIOR) has announced a reverse stock split that will take effect on October 18, 2024. The reverse split will be conducted at a ratio of 1-for-10, meaning that shareholders will receive one new share of Biora Therapeutics for every ten shares they currently hold. Following the split, the company's stock symbol on the market will change from BIOR to BIOR1. The new CUSIP number for Biora Therapeutics will be 74319F404. The pricing for the new BIOR1 symbol will be determined by multiplying the BIOR price by 0.10. The reverse stock split will also result in a new contract multiplier of 100 for options and a new deliverable per contract of 10 new common shares of Biora Therapeutics. This corporate event is expected to affect listed options and futures, with adjustments made by the Options Clearing Corporation (OCC) in accordance with their by-laws.
Biora Therapeutics, Inc. (BIOR) has announced a reverse stock split that will take effect on October 18, 2024. The reverse split will be conducted at a ratio of 1-for-10, meaning that shareholders will receive one new share of Biora Therapeutics for every ten shares they currently hold. Following the split, the company's stock symbol on the market will change from BIOR to BIOR1. The new CUSIP number for Biora Therapeutics will be 74319F404. The pricing for the new BIOR1 symbol will be determined by multiplying the BIOR price by 0.10. The reverse stock split will also result in a new contract multiplier of 100 for options and a new deliverable per contract of 10 new common shares of Biora Therapeutics. This corporate event is expected to affect listed options and futures, with adjustments made by the Options Clearing Corporation (OCC) in accordance with their by-laws.
Biora Therapeutics, Inc. (BIOR)宣佈將於2024年10月18日實施股票拆分。拆分比例爲1股拆分爲10股，意味着股東將獲得每持有十股的Biora Therapeutics股票將獲得一股新的股份。拆分後，公司在市場上的股票標的將從BIOR更改爲BIOR1。 Biora Therapeutics的新CUSIP號碼將爲74319F404。新的BIOR1標的價格將通過將BIOR價格乘以0.10確定。股票拆分還將導致期權的新合約乘數爲100，並且每個合約的交付物爲10股新的Biora Therapeutics普通股。 根據Options Clearing Corporation（OCC）的章程，此次公司事件預計將影響已列出的期權和期貨，OCC將根據其章程對其進行調整。
Biora Therapeutics, Inc. (BIOR)宣佈將於2024年10月18日實施股票拆分。拆分比例爲1股拆分爲10股，意味着股東將獲得每持有十股的Biora Therapeutics股票將獲得一股新的股份。拆分後，公司在市場上的股票標的將從BIOR更改爲BIOR1。 Biora Therapeutics的新CUSIP號碼將爲74319F404。新的BIOR1標的價格將通過將BIOR價格乘以0.10確定。股票拆分還將導致期權的新合約乘數爲100，並且每個合約的交付物爲10股新的Biora Therapeutics普通股。 根據Options Clearing Corporation（OCC）的章程，此次公司事件預計將影響已列出的期權和期貨，OCC將根據其章程對其進行調整。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    英偉達
    NVDA
    -- 142.620
    特斯拉
    TSLA
    -- 406.580
    Palantir
    PLTR
    -- 78.980
    MicroStrategy
    MSTR
    -- 353.670
    Meta Platforms
    META
    -- 647.490
    解鎖完整榜單
    熱門中概股
    追蹤最熱門的中概股實時資訊。
    熱門討論
    中美談話新契機，通脹不再？
    🎙️討論： 1. 特朗普上台後，對華政策如何影響中國資產？ 2. 美股市場通脹風險下降，哪些板塊受益？ 展开
    中國將在明年採取 “適度寬鬆” 的貨幣政策，這是自2011年以來首次轉向寬鬆